DRMA Competitors & Alternatives
Compare Dermata Therapeutics Inc with similar stocks in the same industry
Biotechnology
DRMA
Main Stock$0.72
Tradestie Score
49
Market Cap
$3.50M
Analyst Upside
+459.4%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
SRZN
Surrozen, Inc. Common
|
$31.88
|
$117.07M | - | 34 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$31.15
|
$110.20M | - | 41 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.78
|
$97.42M | - | 33 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.22
|
$84.52M | - | 42 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.66
|
$67.94M | - | 54 | Compare |
|
PALI
Palisade Bio, Inc. Common Stock
|
$1.17
|
$12.21M | 1.9 | 51 | Compare |
|
RNAZ
TransCode Therapeutics, Inc. Common Stock
|
$1.40
|
$8.85M | - | 42 | Compare |
|
ENSC
Ensysce Biosciences, Inc. Common Stock
|
$0.36
|
$7.21M | - | 68 | Compare |
|
BBLG
Bone Biologics Corp Common Stock
|
$0.35
|
$5.01M | - | 56 | Compare |
|
REVB
Revelation Biosciences, Inc. Common Stock
|
$4.36
|
$3.42M | 0.1 | 32 | Compare |
More DRMA Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry